At this stage it is unclear if the Taiwanese government would buy the vaccine. Adimmune is continuing development though so it is ready to produce the vaccine if required.
The H7N9 vaccine may arrive too late and with too little manufacturing capacity to really help, a New Scientist feature warns.
Another vaccine has shown promise in early-stage studies against the virulent H7N9 avian influenza strain, which has so far infected more than 130 people and caused 39 deaths.
As the H7N9 avian influenza outbreak in China grows, global leaders are becoming increasing concerned that the deadly flu virus could mutate into a pandemic.
As the death toll related to H7N9 avian influenza outbreak in China rises to 37, Quebec-based Medicago has reported new positive results from a preclinical trial for an H7N9 vaccine candidate.
Looking to poultry for warning signs of a possible bird flu threat to humans has proved a success in the past. In 2003, H5N1 swept through Asian bird flu populations, forewarning humans. A dead bird sighting then became a cause for alarm around the world.
University of Maryland researchers are developing a new vaccine against H5N1 avian influenza, also known as bird flu, identified by the World Health Organization as a potentially pandemic virus.
Just more than a year after putting a voluntary moratorium on certain experiments involving the H5N1 avian influenza virus, researchers say the studies should restart.
In an effort to cut costs, Indonesia's PT Bio Farma will start producing a vaccine for the bird flu virus by 2013.
After a lingering controversy over bioterror fears that kept a study under wraps for months, investigators have revealed how 5 simple genetic "tweaks" could make the virus spread swiftly among humans.